The Danish Cancer Society Research Center (DCRC) is a research institute within the Danish Cancer Society (DCS) (www.cancer.dk/research/). DCS invests and engages in research to help develop and implement evidence-based responses to current and future challenges in cancer care. Thereby, the DCS contributes to preventing more cancers and to bring forward the day when we can cure most cancer patients.
Danish Cancer Society, Denmark
Tuula Kallunki is a research group leader at the Danish Cancer Society Research Center (DCRC) and Associate Professor at the Institute of Drug Design and Pharmacology, University of Copenhagen. She is specialized in studies of cancer invasion, signal transduction and 3D cultures with cancer cell spheroids and organoids, high-throughput screening and analysis. In DECIDER, Kallunki’s research group focuses on ex-vivo drug experiments on patient derived organoids as well as xenograft experiments. www.cancer.dk/research/dcrc-research/cancer-invasion-and-resistance/group-leader/